We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$4.36B
AUM Growth
+$116M
Cap. Flow
-$72.1M
Cap. Flow %
-1.65%
Top 10 Hldgs %
19.47%
Holding
217
New
12
Increased
50
Reduced
141
Closed
5

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$36M
2
BAC icon
Bank of America
BAC
+$21.3M
3
M icon
Macy's
M
+$18.1M
4
BBWI icon
Bath & Body Works
BBWI
+$16.7M
5
LOW icon
Lowe's Companies
LOW
+$16M

Top Sells

Rank Stock Value
1
ABCO
Advisory Board Co
ABCO
+$19M
2
AMGN icon
Amgen
AMGN
+$13M
3
QGEN icon
Qiagen
QGEN
+$11.8M
4
MET icon
MetLife
MET
+$9.04M
5
GLW icon
Corning
GLW
+$8.57M

Sector Composition

Rank Sector Weight
1 Financials 20.49%
2 Industrials 17.33%
3 Consumer Discretionary 13.49%
4 Technology 13.47%
5 Healthcare 11.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
151
Fastenal
FAST
$54.7B
$798K 0.02%
70,028
-341,820
-83% -$3.68M
MLM icon
152
Martin Marietta Materials
MLM
$31.5B
$778K 0.02%
3,771
-57
-1% -$12K
COST icon
153
Costco
COST
$422B
$776K 0.02%
4,726
-194
-4% -$30.5K
T icon
154
AT&T
T
$159B
$766K 0.02%
25,879
-9,443
-27% -$268K
BA icon
155
Boeing
BA
$171B
$697K 0.02%
2,742
-406
-13% -$94.6K
WM icon
156
Waste Management
WM
$90.6B
$693K 0.02%
8,854
-200
-2% -$15.2K
CLB icon
157
Core Laboratories
CLB
$488M
$681K 0.02%
6,895
-23,339
-77% -$2.26M
UNP icon
158
Union Pacific
UNP
$174B
$674K 0.02%
5,816
+437
+8% +$46.9K
TDG icon
159
TransDigm Group
TDG
$70.2B
$647K 0.01%
2,530
-75
-3% -$20.3K
MO icon
160
Altria Group
MO
$114B
$637K 0.01%
10,043
-3,296
-25% -$220K
CB icon
161
Chubb
CB
$135B
$633K 0.01%
4,443
+306
+7% +$44.3K
AZO icon
162
AutoZone
AZO
$49.2B
$619K 0.01%
+1,040
New +$554K
MRSH
163
Marsh
MRSH
$90.5B
$607K 0.01%
7,239
+1,759
+32% +$139K
QGEN icon
164
Qiagen
QGEN
$8.54B
$606K 0.01%
18,150
-341,231
-95% -$11.8M
PLD icon
165
Prologis
PLD
$135B
$588K 0.01%
9,261
-1,450
-14% -$89.3K
TRI icon
166
Thomson Reuters
TRI
$42.8B
$548K 0.01%
10,297
-12,852
-56% -$686K
EMR icon
167
Emerson Electric
EMR
$83.9B
$529K 0.01%
8,425
-3,018
-26% -$182K
UNH icon
168
UnitedHealth
UNH
$376B
$522K 0.01%
2,667
+29
+1% +$5.6K
HUBB icon
169
Hubbell
HUBB
$25B
$486K 0.01%
4,190
-1,750
-29% -$201K
BDX icon
170
Becton Dickinson
BDX
$45.6B
$455K 0.01%
2,379
-10
-0.4% -$1.94K
MNST icon
171
Monster Beverage
MNST
$94.3B
$442K 0.01%
16,010
+3,800
+31% +$102K
KMB icon
172
Kimberly-Clark
KMB
$36.3B
$400K 0.01%
3,400
-200
-6% -$24.4K
TWX
173
DELISTED
Time Warner Inc
TWX
$368K 0.01%
3,594
-1,880
-34% -$191K
NKE icon
174
Nike
NKE
$61.9B
$367K 0.01%
7,073
-186
-3% -$10.4K
VOD icon
175
Vodafone
VOD
$36.3B
$362K 0.01%
12,736
+1,596
+14% +$46.2K

Similar funds

Douglas Lane & Associates's Q3 2017 Portfolio in Review

As of Q3 2017, Douglas Lane & Associates held 217 positions worth $4.36B, up 2.7% from $4.24B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Douglas Lane & Associates's Q3 2017 filing shows 12 new, 50 increased, 141 reduced and 5 closed positions. Its largest new stake was Brighthouse Financial: 82,983 shares worth $5.04M. The largest sale was Advisory Board Co, an estimated $19M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Douglas Lane & Associates's largest Q3 2017 buy was Brighthouse Financial: 82,983 shares worth $5.04M.
  • Douglas Lane & Associates added most to Oracle in Q3 2017, an estimated $36M increase.
  • Douglas Lane & Associates's biggest Q3 2017 reduction was Advisory Board Co, cutting an estimated $19M.
  • Douglas Lane & Associates fully exited Whole Foods Market Inc in Q3 2017, selling an estimated $4.4M.
  • Douglas Lane & Associates's ten largest holdings make up 19% of its $4.36B portfolio in Q3 2017.
  • Douglas Lane & Associates opened 12 new positions and closed 5 in Q3 2017.
  • Douglas Lane & Associates's portfolio value rose 2.7% quarter-over-quarter to $4.36B.

Based on Douglas Lane & Associates's 13F filing for Q3 2017, filed 19 Oct 2017.